Neutrolis

Neutrolis is a biotech company in Cambridge, United States, founded in 2017. It has raised $23.4M across 2 rounds, most recently a $23.1M Series A in December 2021.

Employees
1–10
Founded
2017
Business Model
B2B
Total Funding
$23.4M
Last Round
$23.1M Series ADec 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Neutrolis advances a clinical-stage pipeline of NET-degrading therapies for autoimmune and inflammatory diseases. Its development work includes building the exDNASE platform to turn its therapeutic approach into medicines, linking that platform with a pipeline focused on degrading NETs as a treatment strategy.

Summary

It lists 1–10 employees. It has raised $23.4M in total across 2 rounds, most recently a $23.1M Series A round in Dec 2021. Investors include Morningside Group and Oceanpine Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries ADec 2021
$23.1M

Sign up to see all 2 events

Funding: Grant through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neutrolis on Indexed.vc
<a href="https://indexed.vc/companies/neutrolis"><img src="https://indexed.vc/api/badge/company/neutrolis" alt="Neutrolis on Indexed.vc" width="260" height="76" /></a>